www.futurescripts.com - Value Formulary eFFectiVe January 1, 2022 - Future Scripts
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Value Formulary Effective January 1, 2022 www.futurescripts.com
INFORMATION FOR MEMBERS AND PROVIDERS The Value Formulary Guide is intended to help members and providers understand prescription drug coverage under the FutureScripts Value formulary. We are committed to providing comprehensive prescription drug coverage. To achieve this, we include a formulary feature in your prescription drug benefit. The drugs are approved by the U.S. Food and Drug Administration (FDA). They are also reviewed by our Pharmacy and Therapeutics Committee, a group of doctors and pharmacists from the area. These prescription drugs have been added to the Value Formulary for their reported medical effectiveness, safety, and value. FutureScripts®, an independent company, is our pharmacy benefits manager. They monitor all drugs to ensure they are safe and effective drugs. Please note: Prescription drug benefits vary by group. Therefore, a drug on this formulary does not imply coverage. Drug coverage is based on medical necessity. This formulary guide was current at the time of printing and is subject to change. Please call Customer Service at the number listed on the back of your ID card if you have any questions about your prescription drug benefits. Please discuss any questions or concerns about your drug therapy with your provider or pharmacist. What is a formulary? A formulary is a list of prescribed medications or other pharmacy care products, services or supplies chosen for their safety, cost, and effectiveness. Medications are listed by categories or classes and are placed into cost levels known as tiers. It includes both brand and generic prescription medications. To create the list, FutureScripts is guided by the Pharmacy and Therapeutics Committee. This group of doctors and pharmacists review which medications will be covered, how well the drugs work, and overall value. They also make sure there are safe and covered options. What are tiers? Tiers are the different cost levels you pay for a medication. Each drug on the formulary is in a tier. Value Formulary Tier Structure The non-preferred tier will usually cost more than the preferred brand tier or generic tier. Below is a summary of tiers in the general order from lowest to highest level of cost-share. Benefits vary by group, so the inclusion of a drug in this formulary does not guarantee coverage. All cost-share tiers may not be available on all plans. - Low-Cost Generic (availability varies by benefit) - Generic - Preferred Brand - Non-preferred Drug - Specialty (availability varies by benefit) - Non-Formulary The non-preferred tier on the formulary is generally associated with higher cost-sharing (i.e., at the higher cost to you) than the preferred brand tier or generic tier. Non-formulary drugs are covered when a formulary exception is obtained through the prior authorization process. Please refer to the Procedures that Support Safe Prescribing in the front of the formulary list for details. Non-formulary drugs are covered when a formulary exception approval has been obtained for which the member will pay the highest, non-specialty level of cost-sharing. 1 (continued)
• G enerally, if a brand-name drug has a generic equivalent, the brand-name drug is non-formulary while the generic equivalent is covered at the generic level of cost-sharing. For example: Cipro® is the brand drug and is considered non-formulary; its generic equivalent ciprofloxacin is available at the generic level of cost-sharing. • Some brand-name drugs without generic equivalents, authorized generic (also referred to as authorized brand alternative) drugs and generic drugs are also considered non-preferred or non-formulary. This is because there are other more cost-effective alternatives covered on the formulary to treat the same condition. Covered generic drugs not listed in the formulary guide are available at the generic level of cost-sharing; brand drugs not listed in the formulary guide are non-formulary. The Low-Cost Generic [LCG] Tier offers copays lower than the cost-share for the generic tier, when possible. This applies to certain generic drugs that are typically used to treat chronic conditions such as high blood pressure, high cholesterol, diabetes, heart failure, and depression. Benefits may vary. Not all plans provide this incentive. The drug list is subject to change. When this incentive is not available on a plan, these drugs will be covered at the generic cost-share level. Specialty Drugs [SP] meet certain criteria, including, but not limited to drugs used to treat rare, complex, or chronic diseases, drugs that have complex storage and/or shipping requirements, and drugs that require comprehensive patient monitoring and/or education. Specialty drugs covered under the pharmacy benefit may be managed by the FutureScripts® Specialty Pharmacy Program. Benefits may vary, and many plans cover specialty drugs on a specialty tier with higher cost-sharing. For cost-sharing purposes, drugs on the specialty tier are not eligible for tier lowering. Authorized Generics [AG] are brand-name drugs that are marketed without the brand name on its label. An authorized generic may be marketed by the brand-name drug company, or another company with the brand company’s permission. These drugs are approved by the FDA. But they are not approved through the abbreviated new drug application (ANDA) process like a standard generic drug. For cost sharing purposes, authorized generics are treated as brand-name drugs and are not eligible for coverage on the generic tier(s). Another name for AGs is Authorized Brand Alternative [ABA]. For example: oxycodone ER tablet, an authorized generic of brand OxyContin®, is listed as non-preferred and is available at the non-preferred level of cost-sharing. What are Affordable Care Act (ACA) Preventive Medications? Certain preventive medications, as described in the Patient Protection and Affordable Care Act and detailed by the U.S. Preventive Services Task Force, are covered without cost-sharing with a prescription when provided by a participating retail or mail-order pharmacy. The following categories of drugs may be available at no member cost-share with a prescription. Please note that individual benefits may vary. Always refer to your benefits to determine your coverage. This list is subject to change. Refer to the searchable drug lookup tool on your health insurance plan’s website to check the status of a specific drug. 2 (continued)
Category Product(s) Available at $0 at the Pharmacy Aspirin products (OTC) aspirin 81mg (tab/chewable) For adults age 50-59 to prevent cardiovascular disease and colorectal cancer; low dose (81mg) for women after 12 weeks’ gestation who are at high risk for preeclampsia Bowel Preparations generic bowel preparation products such as Bowel preparation for colonoscopy needed for Gavilyte-C™, Gavilyte-G™, Gavilyte-N™, preventive colon cancer screening, for ages 45-75 Gavilyte-H™ with bisacodyl, polyethylene glycol (PEG) 3350 oral powder, Trilyte® w/packets Breast cancer chemo prevention tamoxifen 20mg For asymptomatic females age 35 years and older without a prior diagnosis of breast cancer, ductal carcinoma in situ, or lobular carcinoma in situ, who are at high risk for breast cancer and at low risk for adverse effects from breast cancer chemoprevention Contraceptives -Oral: generics such as Amethia, Cryselle-28, Includes, but not limited to, oral, injectable, Emoquette, Fayosim, Necon, Ocella, Sprintec, transdermal, diaphragms, cervical caps, intravaginal Trivora, Natazia devices, female condoms, and contraceptive film and - Injectable: all generics such as medroxyprogesterone jelly (in accordance with the women’s preventive injection services provisions of the ACA). - Transdermal: Xulane® patches Note: IUDs and implantable products are covered - Diaphragms under the medical benefit. - Cervical Caps - Female condoms - Contraceptive film - Contraceptive gel/jelly/foam: such as VCF® foam 12.5%, 28%, Options Conceptrol® 4%, Options Gynol® 3% - Emergency: all generics such as levonorgestrel 1.5mg tab, My Way® 1.5mg tab - Intravaginal devices: etonogestrel-ethinyl estradiol vaginal ring Fluoride sodium fluoride 1.1 (0.5f) mg/ml solution For children ages 6 months to 16 years. sodium fluoride 0.55 (0.25f) mg chewable tab Includes generics strengths up to 0.5mg Fluoritab 0.275 (0.125f) mg/drop solution Fluoritab 1.1 (0.5f) mg chewable tab Folic acid folic acid 400mcg tab For women planning for or capable of pregnancy. folic acid 800mcg tab Limited to 0.4 to 0.8mg of folic acid. folic acid 0.8mg capsule For women younger than 51 years of age (including generic prenatal vitamins with the above listed folic acid dose) 3 (continued)
Category Product(s) Available at $0 at the Pharmacy Tobacco Cessation Medication Chantix® For adults ages 18+ years, who use tobacco products bupropion SR (generic Zyban®) tablet and want to quit nicotine polacrilex lozenge nicotine patch 24 hour transdermal Nicotrol® Inhaler Nicotrol® NS Solution Statins lovastatin 10mg Low-to-moderate dose statin for prevention of lovastatin 20mg cardiovascular disease, recommended for ages 40-75 lovastatin 40mg years without a history of CVD when 1 or more CVD risk factors are present (e.g., dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year risk of a cardiovascular event of 10% or greater HIV PrEP Emtricitabine-Tenofovir Disoproxil Fumarate Tab Preexposure prophylaxis (PrEP) with effective anti- 200-300mg retroviral therapy for persons who are at high risk of Tenofovir 300mg HIV acquisition Vaccines - Influenza: Afluria®, Fluzone [Quad]®, Fluzone®, To prevent certain illnesses in infants, children, and Fluarix®, Flumist®, Flublok®, Fluad®, Flucelvax®, adults. Include immunizations to prevent Influenza, Flulaval® Pneumococcal, and Shingles - Pneumococcal: Prevnar 13®, Pneumovax 23® - Shingles: Shingrix®* * Note: Applies to members at least 50 years of age. Cost share applies for members 18-49 years of age. 4 (continued)
PROCEDURES THAT SUPPORT SAFE PRESCRIBING FutureScripts utilizes an independent pharmacy benefits management (PBM) company, FutureScripts®, to manage the administration of its prescription drug programs. As our PBM, FutureScripts is responsible for providing a network of participating pharmacies, administering pharmacy benefits, and providing customer service to our members and their providers. The effectiveness and safety of drugs and drug-prescribing patterns are monitored by FutureScripts®. Several procedures, such as prior authorization, age limits, and quantity limits, have been established to support safe prescribing patterns and to provide optimal clinical outcomes for members. What is prior authorization? Prior authorization is a requirement that your provider obtain approval from your health plan for coverage of, or payment for, prescription drugs. FutureScripts requires prior authorization of certain covered drugs to confirm that the drug prescribed is medically necessary, clinically appropriate, and is being prescribed according to FDA approved labeled or medically accepted use. The approval criteria were developed and approved by the Pharmacy and Therapeutics Committee, a group of physicians and pharmacists from the area. Using these approved criteria, clinical pharmacists evaluate requests for these drugs based on clinical data, information submitted by the member’s provider, and the member’s available prescription drug therapy history. The clinical pharmacists’ evaluation may include a review of potential drug-drug interactions or contraindications, appropriate dosing and length of therapy, and utilization of other drug therapies, if necessary. Please note, coverage of certain drugs on the formulary (e.g., weight loss drugs) requires a benefit rider. Please contact the health insurance plan for member eligibility information and benefit details. Without prior authorization, the member’s prescription will not be covered at the retail or mail- order pharmacy. The prior authorization review process may take up to two business days once complete information from the provider has been received. Incomplete information may result in a delayed decision. Prior authorization approvals for some drugs may have a limited timeframe, for example six to twelve months. If the prior authorization approval for a drug is limited to a certain time frame, an expiration date will be given at the time the approval is made. If the provider wants a member to continue the drug therapy as requested after the expiration date, a new prior authorization request will need to be submitted and approved for coverage to continue. Safety Edits Safety edits are applied to prescription medications to ensure safe and appropriate use of drugs. They are designed to align with the clinical practice guideline and FDA approved use outlined in the manufacturer package insert. Some of these safety edits will prompt member counseling at the point of sale, while some will require prior authorization review. Safety edits include age limits, quantity limits, morphine milligram equivalent (MME) limits, and concurrent drug utilization review (cDUR). Each safety edit is described below. Age Limits Some drugs, such as zafirlukast, are approved by the FDA only for individuals age five and older. If the member’s prescription falls outside of the FDA guidelines, it may not be covered unless prior authorization is obtained. In addition, an age limit may be applied when certain drugs are more likely to be used in certain age groups. For example, drugs to treat Alzheimer’s disease may require prior authorization for use in young adults. The provider may request coverage for drugs outside of the age limit when medically necessary. The approval criteria for this review were developed and approved by the Pharmacy and Therapeutics Committee. The member should contact the provider to initiate the prior authorization process. 5 (continued)
Quantity Limits Quantity limits are designed to allow a sufficient supply of medication based upon FDA-approved maximum daily doses, standard dosing, and/or length of therapy of a drug. FutureScripts has several different types of quantity limits that are explained in detail below. The purpose of these limits is to ensure safe and appropriate utilization. If a member requires more than the limit, the member’s provider will need to submit a prior authorization request. Similar to other prior authorization requests, quantity limit override requests for certain drugs may have a limited approval timeframe. • Quantity Over Time: This quantity limit is based on dosing guidelines over a rolling time period. For example, if a drug has a quantity limit over a 30-day time period and a member went to the pharmacy on January 1, 2022, for one of these medications, the plan would have looked back 30 days to December 2, 2021, to see how much medication was dispensed. The purpose of these limits is to prevent the dispensing of excessive quantities. Examples of quantity limits over time are: ◦ Etonogestrel-ethinyl estradiol (Nuvaring®) = 1 ring per 28 days ◦ Ibandronate (Boniva®) 150mg = 1 tablet per 30 days ◦ Sumatriptan (Imitrex®) 50mg = 18 tablets per 30 days ◦D iabetic supplies such as blood glucose test strips = 200 strips per 30 days ◦ Sildenafil (Viagra®), tadalafil (Cialis® 10mg, 20mg) = 8 tablets per 30 days • Maximum daily dose: This quantity limit defines the maximum number of units of the drug allowed per day. Examples of maximum daily dose quantity limits are: ◦ Zolpidem (Ambien®) = 1 tablet per day ◦ Oxycodone/acetaminophen (Percocet®) 5/325mg = 12 tablets per day ◦ Guanfacine Extended Release 24 Hour = 1 tablet per day • Refill too soon: This limit is in place to encourage appropriate utilization and minimize stockpiling of prescription medications. Based on this edit, a member can receive a refill of a prescription after 75% utilization. Additional refills will be covered once 75% of the supply has been consumed. The following examples illustrate how refill too soon limit works: ◦ A 30 days’ supply of a prescription filled on 1/1/2022 will be refillable again on or after 1/24/2022 ◦ A 90 days’ supply of a prescription filled on 7/1/2022 will be refillable again on or after 9/7/2022 • Day Supply Limit: This limit is based on the day supply and not the quantity. However, quantity limits may apply as well. Day Supply Limits apply to some classes of drugs, such as opioids. If a quantity limit applies, the member will also be limited to the maximum daily dose for that drug. The following are examples of drugs that have a day supply and a quantity limit: ◦ Short acting opioids, such as oxycodone/acetaminophen 5mg/325mg •D ay supply limit = Two 5 days’ supplies limit per 60 days for adults, two 3 days’ supply limit for children under 18 years of age. ◦ Butalbital containing headache agents, such as butalbital/aspirin • Day supply limit = 5-day supply per 30 days • Quantity Limit = 6 tablets per 1 day •M aximum quantity allowed without prior authorization = 30 tablets (6 tablets per day for 5 days) 6 (continued)
◦ Opioid containing cough and cold products, such as hydrocodone/homatropine •D ay supply limit = Two 5-days’ supplies limit per 60 days for adults, and two 3 days’ supply limit for children under 18 years of age • Quantity Limit = 30 ml per 1 day • Maximum quantity allowed without prior authorization = 150 ml (30 ml per day for 5 days) Morphine Milligram Equivalent (MME) Limit FutureScripts applies additional safety measures to opioid products by limiting the total daily dose. This limit accounts for various opioid products through a measurement called the Morphine Milligram Equivalent (MME) dose. The MME is a number that is used to determine and compare the potency of opioid medications. It helps to identify when additional caution is needed. The daily limit is calculated based on the number of opioid drugs, their potencies and the total daily usage. Prior authorization is required for an opioid dose that exceeds 90 MME per day. MME Limit applies to the opioid products containing the active ingredients listed below: Active Ingredient codeine dihydrocodeine fentanyl hydrocodone hydromorphone levorphanol meperidine methadone morphine Opium oxycodone oxymorphone tapentadol Tramadol benzhydrocodone Cumulative Stimulant Limit Central nervous system (CNS) stimulants such as amphetamine and methylphenidate, when used in high doses, are associated with increased risk for cardiac related adverse events such as hypertension and new or worsening psychosis including manic behavior. Cumulative stimulant limit is a safety measure designed to ensure the provider has assessed the members for alternative medication and advised the members about the risks associated with stimulant use. The cumulative stimulant limit works by calculating the total daily stimulant dose by the drug’s active ingredient. Stimulant claims that exceed the limit outlined below would require prior authorization. Active ingredient Medications impacted High cumulative daily dose (brands and generics) Amphetamine Adzenys ER[ODT], Dyanavel, 60mg/day Evekeo [ODT] Amphetamine-Dextroamphetamine Adderall [IR/XR], Mydayis 60mg/day Dextroamphetamine Dexedrine, Zenzedi, ProCentra 60mg/day Lisdexamfetamine Vyvanse 70mg/day Methamphetamine Desoxyn 60mg/day Dexmethylphenidate Focalin [IR/XR] 40mg/day Methylphenidate Ritalin [IR/LA], Daytrana, 72mg/day Cotempla, Metadate [ER/CD], Methylin, Quillivant XR, Concerta, Aptensio XR, QuilliChew ER, Jornay PM, Adhansia XR *Prior authorization and other safety edits including quantity limit and age limit continue to apply. 7 (continued)
Concurrent Drug Utilization Review (cDUR) These reviews are built into the pharmacy claim adjudication system to review a member’s prescription history for possible drug related problems including drug-drug interactions and drug therapy duplications. Drugs may reject at the Point-of-Sale (POS) and/or generate a message to the dispensing pharmacist when there is a safety concern. The dispensing pharmacist can review the issue with the provider and override the rejection if appropriate for most edits. Examples of cDURs are: • Drug-drug interaction: sildenafil (Viagra®/Revatio®) and nitroglycerin in combination may lead to potentially fatal hypotension. • Drug therapy duplication: Simvastatin and atorvastatin in combination will trigger a message in the claim adjudication system to alert the dispensing pharmacist there is a duplication of statin therapy. To determine if a covered prescription drug prescribed for you has a prior authorization requirement, an age limit, a quantity limit, or a morphine milligram equivalent (MME) limit, see the plan website at https://www. ibx.com/rx or call FutureScripts® at the phone number on the back of your ID card. 96-Hour Temporary Supply Program The 96-Hour Temporary Supply Program is available for non-formulary medications and certain formulary medications that require prior authorization. Under the 96-Hour Temporary Supply Program, the dispensing pharmacist has the option to release a 96-hour supply as follows: 1. The dispensing pharmacist may place an override to release a 96-hour supply of the drug to the member with either no out-of-pocket co-pay or the appropriate percentage cost-sharing as defined by the member’s benefit. 2. The next business day, FutureScripts®, will contact the member’s provider to request submit documentation of medical necessity or medical appropriateness for review. 3. Once the completed medical documentation is received by FutureScripts®, the review will be completed, and the request will either be approved or denied. 4. If approved, the remainder of the prescription may be filled, and the appropriate prescription drug out-of-pocket cost-sharing will be applied. 5. If denied, notification will be sent to both the provider and the member. Obtaining a 96-hour temporary supply does not guarantee that the prior authorization request will be approved. This program limits a one-time release of 96-hour supply per drug. Some drugs are not eligible for the 96-Hour Temporary Supply Program due to packaging or other limitations. How to submit a Prior Authorization? Here is the process to request a prior authorization/preapproval or override: 1. The provider prescribing the drug can access electronic prior authorization (ePA) platforms such as CoverMyMeds® and SureScripts™ to submit a prior authorization request. Alternatively, the provider can complete a prior authorization fax form or write a letter of medical necessity and submit it to FutureScripts® by fax at 1-888-671-5285. The forms are available online at: https://www.futurescripts. com/prior-authorization1.html. 2. FutureScripts® will review the prior authorization request or letter of medical necessity. If a clinical pharmacist cannot approve the request based on established criteria, a medical director will review the document. 8 (continued)
3. A decision is made regarding the request. • If approved, the provider will be notified of the approval via fax and/or telephone, and the pharmacy claim adjudication system will be coded with the approval. Note: ePA approval can occur in real time, this means the member can be approved for the drug prior to leaving the provider’s office with a prescription. The member may call the Customer Service phone number on his or her ID card to determine if the request is approved. • If denied, the prescribing provider will be notified via letter, fax, or telephone. The member is also notified via letter. The appeals process is detailed within the denial letters sent to the member and provider. Formulary Exception Requests Non-formulary drugs: Providers may request consideration for coverage of a non-formulary medication when there has been a trial of, or contraindication to, at least three formulary alternatives when applicable. Tier exceptions: Providers may request consideration for preferred coverage of a non-preferred drug when there has been a trial of, or contraindication to, at least three formulary alternatives when applicable. • Requests for a generic medication that is located on the non-preferred drug tier to be lowered to the generic tier will be approved if the exception criteria are met. • Requests for a brand medication or an authorized generic (also referred to as authorized brand alternative) non-preferred that is located on the non-preferred drug tier to be lowered to the preferred brand tier will be approved if the exception criteria are met. Please note, restrictions apply to formulary exception requests. Drugs on the generic tier, the preferred brand tier and the specialty tier are not eligible for tier exceptions. Tier exceptions are not available under some plans; please refer to the member benefit booklet for details. When requesting an exception, the provider should complete the formulary exception request form, providing detail to support the request, and fax the request to 1-888-671-5285. If the formulary exception request is approved for a non-preferred drug, the drug will pay at the appropriate preferred brand or generic level of cost-sharing. If the request is denied, the member and provider will receive a denial letter with the appropriate appeals language. The forms are available online at: https://www.futurescripts.com/prior-authorization1.html. Appealing a decision If a request for prior authorization or exception results in a denial, the member, or the provider on the member’s behalf (with the member’s consent), may file an appeal. Both the member and his or her provider will receive written notification of a denial, which will include the appropriate telephone number and address to direct an appeal. To assist in the appeals process, it is recommended that the provider be involved to provide any additional information on the basis of the appeal. 9 (continued)
Prior authorization applies to all formulations of the following specific drugs, including but not limited to, tablet, capsule, and oral suspensions.* abiraterone Bronchitol® Dojolvi™ Fortamet® Actemra® SC Brukinsa™ doxepin tablet Fotivda® Actimmune® buprenorphine patch doxycycline hyclate tab Freestyle test strips/ adapalene pad Bynfezia Pen™ 50mg glucometer Addyi® Byvalson™ doxylamine-pyridoxine Fulyzaq™ Adempas® Cabometyx™ droxidopa Fuzeon® Admelog® Calquence® Dupixent® Gattex® Advate® Caprelsa® Duzallo® Gavreto™ Gavreto ™ Adynovate® Carac® Ecoza™ Gilotrif™ Afstyla® Carbaglu® Edarbi™ Gleevec® Albuterol HFA Carbatrol® Edex® Glucagen® Hypokit® (AG for Ventolin) Caverject® Edluar™ Gonal-f ® Alecensa® Cayston™ Elmiron® Grastek® Alphanate® Cerdelga™ Eloctate™ Haegarda® Alphanine® SD Cholbam® Emflaza™ Harvoni™ Alprolix™ Ciclodan® Emgality® Helixate® FS Altabax™ Cimzia® Empaveli™ Hemlibra® Soln Alunbrig™ Cinryze® Enbrel® Hemofil® M amphetamine clindamycin/benzoyl Endari™ Hetlioz™ (generic Evekeo) peroxide 1%/5% Enspryng™ Enspryng ™ Horizant™ Apidra® clobazam Epclusa ® Humalog® Apidra® SoloSTAR® Cloderm® Erivedge™ Humate-P® Apokyn® clovique Erleada® Humatrope® Aptiom® Coagadex® erlotinib Humira® armodafinil Cometriq™ Ertaczo® Hycamtin® Austedo™ Contour Glucometer Esbriet® hydrocodone ER Auvi-Q® 0.1mg Contour Next Test Strips esomeprazole hydromorphone ER Ayvakit™ Contour Test Strips esomeprazole granules Ibrance® azelastine/fluticasone Contrave ER® Esperoct® icatibant inj spray Corifact® eszopiclone 3mg Iclusig™ Bebulin® Corlanor® Eucrisa™ Idhifa® Belbuca™ Cosentyx™ everolimus (generic for Ilevro® Belviq® [XR] Cotellic™ Afinitor) imatinib mesylate BeneFIX® Cresemba® Evrysdi™ Evrysdi ™ Imbruvica™ Benlysta® Cutivate® Exelderm® Imcivree™ Imcivree ™ Benzamycinpak® cyclobenzaprine ER Factive® imiquimod benzphetamine Cystadrops® Fanapt™ Increlex® Berinert® Cystaran™ Farydak® indomethacin 20mg Bevespi Aerosphere™ Daklinza™ dapsone gel Fasenra® Ingrezza™ bexarotene 7.5% febuxostat Inlyta® Bonjesta® Daytrana™ Feiba® Inqovi® bosentan deferasirox tab/granules Femring® Inrebic® Bosulif® deferiprone fentanyl citrate-OTFC insulin lispro Brand prenatal vitamins1 dexchlorpheniramine soln fentanyl transdermal insulin lispro inj junior Bravelle® D.H.E.® 45 Fetzima™ insulin lispro inj protamin Breeze2 test strips/ Diabetic test strips2 Fioricet® with Codeine Intrarosa® glucometer diclofenac gel 3% Fiorinal® with Codeine Invokamet® [XR] Briviact® diethylpropion HCL Firazyr® Invokana® BromSite® dihydroergotamine Flector® patch Iressa® 11 (continued)
Isturisa® Motegrity™ orphenadrine-asa caffeine Revlimid® Ixinity® Muse® Otezla™ Rexulti® Jakafi™ Myalept™ Oxaydo® Riastap® Jublia® Mycapssa® Oxbryta™ Rinvoq™ Juxtapid™ Mytesi™ oxiconazole nitrate Jynarque® Nascobal® Oxtellar® XR Rixubis™ Kalydeco™ Natpara® oxycodone ER Rozlytrek™ ketoprofen cap Nayzilam® Oxycontin® Rubraca® Keveyis™ Nerlynx™ oxymorphone ER Ruconest® Kevzara® Nestabs® One Palforzia™ cap/powder rufinamide Kineret® Nexavar® pantoprazole pak Rukobia® Kisqali™ Nexletol™ Pemazyre™ Ruzurgi® Klisyri® Nexlizet™ penicillamine capsule Rydapt® Koate®-DVI Ninlaro® Percocet® Rytary™ Kogenate® FS nitisinone phendimetrazine tartrate sapropterin pow/tab Korlym™ Nityr® phentermine hcl Saxenda® Koselugo™ Non Preferred Diabetic Picato® Sernivo™ Kynamro® Meters Piqray® Serostim® Kynmobi™ Norditropin® Pogo Automatic® Sevenfact® lansoprazole solutab Nourianz™ Mis Monitor Signifor® lapatinib Novoeight® Pogo Automatic® sildenafil Lastacaft® Novoseven® RT Test Cartridge Siliq™ Latuda® Noxafil® Pomalyst® Simponi™ ledipasvir-sofosbuvir Nubeqa™ Praluent® Sirturo™ Lenvima™ Nucala® Soln Precision Glucometer Skyrizi™ Levemir® Nucynta ER® Precision XTRA Test sofosbuvir-velpatasvir levothyroxine cap Nuedexta™ Strips Solosec® Livalo® Nulibry™ Nulibry ™ pregabalin ER tab Somavert® Lomaira™ Nuplazid™ Pretomanid® Sovaldi™ Lonhala™ Magnair™ Nurtec™ Prilosec® Sprycel® Lonsurf® Nutropin® (AQ) Proctocort® Supp 30mg Stelara® Lorbrena® Procysbi® Stivarga® Nuwiq® luliconazole cream Profilnine® Strensiq™ Obizur® Lumakras™ Promacta® Striant® Ocaliva™ Lupkynis™ Lupkynis ™ Qinlock™ Sucraid® Odactra® SL Luzu® Qsymia® ER sumatriptan/naproxen Odomzo® Lynparza™ Qudexy® XR Sunosi™ Ofev® Mavenclad Pak® QuilliChew ER™ Sutent® Olumiant® Mavyret™ Quillivant XR™ Sylatron™ Omnaris® Mekinist® quinine sulfate Symlin® Ongentys® meloxicam cap rabeprazole Sympazan™ Film Onureg® Menopur® Ragwitek™ Tabrecta™ Onzetra Xsail™ Metaxalone Rasuvo™ tadalafil (generic Adcirca) Opsumit® methadone Ravicti™ Tafinlar® Oralair® Methitest™ Rebif® Rebidose® Tagrisso™ Orencia® SQ methyltestosterone Rebinyn® Taltz Autoinjector® Orenitram™ miglustat Recombinate™ Targretin® Gel Orfadin® modafinil Regranex® Tasigna® Orgovyx™ Orgovyx ™ mometasone furoate ReliOn® tavaborole Oriahnn® Monoclate-P® Repatha™ Tazverik™ Orkambi™ Monodox® Retevmo™ Technivie™ Orladeyo® Mononine® morphine ER Retin-A® (Micro) Tegretol® [XR] 11 (continued)
Tekturna® (HCT) Turalio™ Vonvendi Xultophy® temozolomide Tymlos™ Vosevi™ Xuriden™ Tepmetko® Tyvaso® Votrient™ Xyntha® Teriparatide® inj Ubrelvy™ Vusion® Xyrem® testosterone enanthate Ukoniq® Vyleesi™ Xywav™ Xywav ™ testosterone topical Uloric® Vyndamax® Yupelri™ Yupelri™ Thalomid® Upneeq® Vyndaqel® Zejula™ Thyquidity™ Uptravi® Wakix® Zelboraf® Tirosint® Utibron™ Neohaler Wegovy™ Zelnorm™ tolvaptan Valchlor™ Wilate® Zembrace Symtouch™ topiramate ER sprinkle Valtoco® Xalkori® Zepatier™ Toviaz™ vardenafil [ODT] Xcopri® Zerviate™ Zerviate™ Tremfya™ Vascepa® Xeljanz® [XR] Zetonna™ Tresiba® Vecamyl™ Xenazine™ zileuton ER tab tretinoin caps Venclexta® Xenical® Zioptan® Tretten® Ventavis® Xermelo™ Zokinvy® triamcinolone 0.05% Verdeso® Xhance™ MIS 93mcg Zolinza® ointment Verquvo™ Verquvo ™ Xifaxan® Zolpidem 10mg Trianex® Verzenio™ Xiidra™ Zolpidem ER 12.5mg trientine Viberzi™ Xolair® Zolpidem SL 3.5mg Trikafta™ Viekira Pak™ Xospata® Zurampic® Trintellix® vigabatrin pack/tab Xpovio® Zydelig® Tritocin™ vigadrone pack Xpovio® Pak Zykadia™ Trokendi®XR Viibryd® Xtampza® XR Truseltiq™ Voltaren XR® Xtandi® Tukysa™ 1 All brand prenatal vitamins require prior authorization. All diabetic test strips require prior authorization except for OneTouch®. 2 * Compound products with total cost equal to or greater than $75 per prescription. 12
Reading the formulary drug list How can I tell if a drug is generic or brand? The formulary gives you choices so you and your doctor can decide your best course of treatment. In this formulary, brand-name medications start with an uppercase letter and are written in bold. Generic medications are shown in lowercase and in italic. Brand name Drug Starts with UPPERCASE in Bold Ex: Augmentin Generic drug Lowercase italic Ex: avidoxy Tier information Tiers are the different cost levels you pay for a medication. Each drug on the formulary is in a tier. Below is a reference guide to use as you review your formulary to see the abbreviation for each drug tier on the formulary list. Drug Tier Abbreviation Generic G Non-preferred Drug NPD Specialty Drug SP Low-cost Generic LCG Preferred Brand PB Non-Formulary NF $0 Preventive Drug ACA Drug list requirements and/or limits Some medications are noted with letters next to them to help you see which drugs may have coverage requirements and/or limits. Below is a reference guide to use as you review your formulary to see the abbreviation for each requirement/limit on the formulary list. Requirements/Limits Abbreviation Prior Authorization PA Quantity Limits Apply QL Age Limit AL Limited Distribution Drug LDD Day Supply Limit 5DS Requires Rider R Quantity Over time Q/T Morphine Milligram Equivalent MME PA for Selected NPD + 13
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS ANTIBIOTICS & OTHER DRUGS USED FOR Avelox NF INFECTION avidoxy G abacavir sulfate azithromycin G G tab, soln Bactrim, Bactrim DS NF abacavir sulfate/ G lamivudine Baraclude NF, SP abacavir/ Baxdela NF QL lamivudine/ G Benznidazole NPD zidovudine Bethkis NF, SP Acticlate NF AL Biaxin NF acyclovir LCG Biktarvy NPD acyclovir cream G QL Biltricide NF 5% cefaclor G adefovir dipivoxil G, SP cefaclor ER G Aemcolo DR NPD QL cefadroxil G albendazole G cefdinir G Albenza NF cefixime susp/cap G Alinia susp NPD QL ceftibuten G Alinia tab NF QL Ceftin NF Altabax NPD PA cefuroxime axetil G Amoxicillin 775mg PB cephalexin G amoxicillin G chlorhexidine amoxicillin/ G G gluconate soln clavulanate chloroquine amoxicillin/ G phosphate clavulanate G Cimduo NPD extended-release Cipro NF ampicillin G Cipro XR NF Amzeeq NF ciprofloxacin ER Ancobon NF G tabs Arakoda NPD ciprofloxacin LCG Arikayce Susp NPD, SP PA clarithromycin G atazanavir G clarithromycin ER G atovaquone G Cleocin NF atovaquone/ clotrimazole G G proguanil troches Atripla NF Combivir NF Augmentin NF Complera PB Augmentin XR NF Cresemba NPD PA, QL Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 14
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS Crixivan PB efavirenz G Daklinza NPD, SP PA, Q/T, QL efavirenz- dapsone tablet G emtricitab- G Daraprim Tab NF, SP tenofovir tab Daxbia NPD efavirenz- lamivudine- G Delstrigo NPD tenofovir tab demeclocycline G Egaten 250mg dicloxacillin G NPD tablet didanosine G emtricitabine cap G Dificid Tab/Susp NPD QL emtricitabine- Diflucan NF tenofovir disoproxil Doryx 50mg fumarate tab G NF tablet 100-150mg, 133- Doryx 200mg 200mg, NF QL 167-250mg tablet Dovato NPD emtricitabine- tenofovir doxycycline DR disoproxil G, ACA QL NF 40mg fumarate tab doxycycline 200-300mg NF hyclate DR 80mg Emtriva NF Doxycycline Emverm NPD QL hyclate tab 75mg, NPD AL 150mg entecavir G, SP Doxycycline Epclusa PB, SP PA, Q/T, QL hyclate tab 50mg NPD PA Epivir NF Doxycycline Epzicom NF hyclate tab DR NPD EryPed 50mg, 100mg NF 400mg/5ml Susp Doxycycline hyclate tab DR NPD QL, QT Ery-Tab NF 200mg Erythrocin NPD doxycycline erythromycin G monohydrate cap G delayed release 50mg, 100mg erythromycin G Doxycycline ethylsuccinate monohydrate cap NPD AL erythromycin 75mg, 150mg G stearate Doxycycline ethambutol G monohydrate tab NPD AL 150mg etravirine G Edurant PB famciclovir G E.E.S. 400mg tab NF Firvanq Soln NPD AL Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 15
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS Flagyl NF lamivudine 100mg G, SP fluconazole tab G suspension/tabs lamivudine/ G flucytosine G zidovudine Flumadine NF Lampit NPD fosamprenavir Ledipasvir- G sofosbuvir tablet NPD, SP PA, QL calcium tab 90-400mg fosfomycin pow G Levaquin NF Fuzeon NPD PA levofloxacin G Gris-PEG NF Lexiva NF griseofulvin linezolid G QL G microsize lopinavir/ritonavir G griseofulvin G Macrodantin NF ultramicrosize Malarone NF Harvoni PB, SP PA, Q/T, QL Mavyret PB, SP PA, Q/T, QL Hepsera NF, SP mefloquine G Hiprex NF Mepron NF Humatin NF methenamine hydroxy- G G hippurate chloroquine metronidazole LCG Impavido NPD Q/T, QL Minocin NF Intelence NF minocycline caps G Invirase PB Minocycline ER Isentress PB cap NF Q/T isoniazid G minocycline ER itraconazole G Q/T G tablet ivermectin G Minolira NF Q/T Juluca NPD moderiba G, SP Kaletra soln/tabs NF Mondoxyne NL 75mg cap NPD AL Kalydeco Tabs/ Pack NPD, SP PA, LDD Monurol Pak Granules NF Keflex NF ketoconazole tabs G Moxatag NPD Krintafel NPD moxifloxacin hcl G Lamisil Tabs NF Myambutol NF lamivudine Mycobutin NF 150mg, 300mg G Mytesi + NPD PA tablets Nebupent INH NF nevirapine G Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 16
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS nevirapine ER G Rifadin NF nitazoxanide G QL rifampin G nitrofurantoin rimantadine G G macrocrystals ritonavir G nitrofurantoin Rukobia NPD PA G AL susp Selzentry PB Norvir powder PB Seysara NF Q/T Norvir tablet NF Sirturo NPD PA Noxafil NF QL Sitavig NPD QL Nuzyra NPD QL Sivextro NF Onmel NF Sklice Lot 0.5% NF Oracea NF sofosbuvir- Orkambi tablet/ velpatasvir tablet NPD, SP PA, QL NPD, SP PA, LDD packet 400-100mg oseltamivir caps/ Solodyn NF QL, Q/T G QL susp Solosec GRA NPD PA Pegasys NPD, SP Sovaldi NPD, SP PA, QL, Q/T PegIntron NPD, SP Sporanox NF penicillin v G SSKI Solution NPD potassium tablet stavudine G pentamidine INH G Stribild PB Pifeltro NPD Stromectol NF Plaquenil NF QL sulfamethox- posaconazole G QL LCG azole/tmp praziquantel G Suprax Susp Pretomanid NPD PA 100mg/5ml, NF Prevymis NPD, SP 200mg/5ml Prezista PB Sustiva NF pyrimethamin G, SP Symfi NF Qualaquin NF Symfi Lo NF quinine sulfate G PA Symtuza NPD Relenza NPD QL, AL Talicia NPD Retrovir NF Tamiflu NF QL Reyataz NF Targadox NF ribasphere Technivie NPD, SP PA, Q/T, QL ribapak Temixys NPD G, SP 200mg & 400mg/ tenofovir G 400mg & 600mg terbinafine tabs LCG rifabutin G Tindamax NF Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 17
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS tinidazole G Xofluza Therapy Pack NPD Q/T Tivicay PD NPD Tobi Nebulization Zepatier NPD, SP PA, Q/T, QL Soln NF, SP Zerit NF Tobi Podhaler Ziagen NF Cap NPD, SP zidovudine LCG tobramycin Zithromax NF G, SP nebulization soln. Zmax NF Tolsura NF Zyvox NF QL Trikafta NPD, SP PA Triumeq PB CANCER & ORGAN TRANSPLANT DRUGS Trizivir NF abiraterone G, SP PA Truvada NF Afinitor NF, SP valacyclovir tab G Alecensa NPD, SP PA Valcyte NF Alkeran NF, SP valganciclovir G Alunbrig tab/pak NPD, SP PA Valtrex NF anastrazole G vancomycin G Arimidex NF Vemlidy NPD, SP Aromasin NF Vfend NF Ayvakit NPD, SP PA, QL Vibramycin NF azathioprine G Videx EC NF Balversa NPD, SP PA Viekira Pak NPD, SP PA, QL, Q/T Benlysta NPD, SP PA Viekira XR NPD, SP PA, QL, Q/T bexarotene G, SP PA Viramune bicalutamide G suspension NF Bosulif NPD, SP PA Viramune tablet NF Braftovi NPD, SP PA Viramune XR NF Brukinsa NPD, SP PA Viread NF Cabometyx NPD, SP PA Vocabria NPD Calquence NPD, SP PA voriconazole G capecitabine G, SP Vosevi PB, SP PA, Q/T, QL Caprelsa NPD, SP PA Xenleta NPD QL Casodex NF Xepi Cream NF Cellcept NF 0.1% Xifaxan 200mg NPD QL Cometriq NPD, SP PA Xifaxan 550mg NPD PA, Q/T, QL Copiktra NPD, SP PA Ximino ER NF Q/T Cotellic NPD, SP PA, LDD Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 18
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS cyclophosphamide imatinib mesylate G, SP PA G caps Imbruvica NPD, SP PA Cyclophospha- Imuran NF mide tabs NPD Inlyta NPD, SP PA cyclosporine G Inqovi tab NPD, SP PA Cytoxan NPD, SP Inrebic NPD, SP PA danazol G Iressa tab NPD, SP PA Danocrine NPD Kisqali NPD, SP PA, LDD Daurismo NPD, SP PA Koselugo NPD, SP PA Deltasone NPD lapatinib G, SP PA Emcyt NPD Lenvima NPD, SP PA, LDD Erivedge NPD, SP PA letrozole G Erleada NPD, SP PA leucovorin G erlotinib G, SP PA calcium etoposide G, SP Leukeran PB Eulexin NPD leuprolide G, SP everolimus Lonsurf NPD, SP PA (generic for G, SP PA Lorbrena NPD, SP PA Afinitor) Lumakras NPD, SP PA everolimus (generic for G Lupkynis NPD, SP PA, QL Zortress) Lynparza PB, SP PA exemestane G Lysodren NPD Fareston NF Matulane PB, SP Farydak NPD, SP PA, LDD Mavenclad pak + NPD, SP PA Femara NF Megace NF flutamide G megestrol acetate G Fotivda NPD, SP PA Mekinist NPD, SP PA Gavreto NPD, SP PA Mektovi NPD, SP PA Gilotrif NPD, SP PA melphalan G, SP Gleevec NF, SP mercaptopurine G Gleostine NPD, SP Mesnex NPD, SP Hexalen NPD methotrexate tab G Hycamtin NPD, SP PA mycophenolate G Hydrea NF mycophenolic acid G hydroxyurea G Myfortic NF Ibrance NPD, SP PA, LDD Myleran NPD Iclusig NPD, SP PA Neoral NPD Idhifa NPD, SP PA Nerlynx NPD, SP PA Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 19
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS Nexavar NPD, SP PA Tagrisso NPD, SP PA Nilandron NF, SP Talzenna NPD, SP PA nilutamide G, SP tamoxifen G Ninlaro NPD, SP PA Tarceva NF, SP Nubeqa NPD, SP PA Targretin cap NF, SP Odomzo NPD, SP PA Tasigna NPD, SP PA Onureg NPD, SP PA Tazverik 200mg NPD, SP PA Orgovyx tab NPD, SP PA Temodar NF, SP Ortikos ER Cap NF temozolomide G, SP PA Pemazyre NPD, SP PA Tepmetko NPD, SP PA Piqray NPD, SP PA Thalomid NPD, SP PA Pomalyst NPD, SP PA Tibsovo NPD, SP PA prednisone LCG toremifene G prednisone tretinoin caps G, SP PA therapy pack/ Trexall tab NPD G solution/ concentrate Truseltiq NPD, SP PA Prograf capsule/ Tukysa NPD, SP PA packet NPD Turalio NPD, SP PA Protopic NF Tykerb NF, SP Purixan NPD, SP Ukoniq NPD, SP PA Qinlock tab NPD, SP PA Valchlor NPD, SP PA Rapamune Venclexta NPD, SP PA tab/sol NF Verzenio NPD, SP PA RediTrex Inj NF Vitrakvi NPD, SP PA Retevmo cap NPD, SP PA Vizimpro NPD, SP PA Revlimid NPD, SP PA Votrient NPD, SP PA Rozlytrek NPD, SP PA Xalkori NPD, SP PA Rubraca PB, SP PA Xatmep NPD AL Rydapt NPD, SP PA Xeloda NF, SP Sandimmune NF Xospata NPD, SP PA sirolimus tab/soln G Xpovio NPD, SP PA Sprycel NPD, SP PA Xpovio Pak NPD, SP PA Stivarga NPD, SP PA Xtandi NPD, SP PA, LDD Sutent NPD, SP PA Yonsa NPD, SP PA Tabloid NPD Zejula PB, SP PA, LDD Tabrecta tab NPD, SP PA Zelboraf NPD, SP PA, LDD tacrolimus G Zolinza NPD, SP PA, LDD Tafinlar NPD, SP PA Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 20
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS Zortress NF amphetamine Zydelig NPD, SP PA, LDD aspartate/ amphetamine G QL Zykadia NPD, SP PA, LDD sulfate/dextro- Zytiga NF, SP LDD amphetamine amphetamine PAIN, NERVOUS SYSTEM, & PSYCH aspartate/ Abilify NF amphetamine G QL sulfate/dextro- Abilify Mycite NF amphetamine ER Abilify Mycite Amphetamine Maintenance/ NF NF QL ER suspension Starter Pak amphetamine Abstral NF QL, MME tablet (generic G PA, QL acamprosate DR Evekeo) G tab Anafranil NF acetaminophen QL, 5DS, AL, LCG Antabuse NF w/codeine MME PA, QL, 5DS, Actiq NF QL, MME Apadaz + NPD MME Adderall NF QL Aplenzin NF Adderall XR NF QL Apokyn Solution Adhansia XR Cartridge 30 NPD, SP PA NF QL Capsule MG/3ML Adipex-P NF R Aptensio XR NF QL Adzenys ER susp NF QL Aptiom NPD PA Adzenys XR- Aricept [ODT] NF AL NF QL ODT aripiprazole G Aimovig PB PA armodafinil G PA Ajovy NF Arymo ER NF QL, MME Allzital 25- NF QL, 5DS asenapine sub G 325mg Ativan NF AL almotriptan G QL, AL atomoxetine G QL maleate alprazolam LCG AL Aubagio NPD, SP alprazolam ER G AL Austedo NPD, SP PA amantadine G Avonex PB, SP QL Ambien NF QL Axert NF QL, AL Ambien CR NF QL Azilect NF Amerge NF QL, AL Banzel Susp NF AL amitriptyline G Banzel Tab NF amoxapine G Belbuca PB PA, QL, MME Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 21
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS Belsomra NF QL butorphanol QL, 5DS, AL, G Belviq [XR] NPD PA, R tartrate nasal MME Benzhydro- Butrans NF QL, MME PA, QL, 5DS, codone-aceta- NPD Cafergot NF minophen + MME Caplyta NF benzphetamine LCG R carbamazepine G benztropine G carbamazepine G AL Betaseron PB, SP QL susp Brisdelle cap NF QL carbamazepine XR G Briviact Carbatrol NPD PA suspension NPD PA, AL carbidopa G Briviact tablet NPD PA carbidopa/ G Bromocriptine levodopa mesylate NF carbidopa/ G Bunavail NF QL levodopa ER buprenorphine carbidopa/ G QL G hcl/naloxone hcl levodopa ODT buprenorphine carbidopa/ G PA, QL, MME levodopa/ G patch entacapone buprenorphine SL G QL carisoprodol- QL, 5DS, AL, bupropion G G aspirin-codeine MME bupropion ER Cataflam NF G QL 150mg Celexa NF Bupropion ER Celontin NF PB 450mg Chantix ACA QL bupropion SR G chlordiazepoxide G AL bupropion XL G chlorpromazine buspirone G G HCl Butalbital- citalopram LCG acetaminophen NF QL, 5DS 25-325mg clobazam G PA Butalbital- clobazam susp G PA, AL acetaminophen NF QL, 5DS clomipramine HCl G 25-300mg clonazepam G butalbital/apap/ G QL, 5DS clorazepate caffeine G AL dipotassium butalbital/apap/ QL, 5DS, AL, G clozapine G caffeine/codeine MME butalbital/aspirin/ QL, 5DS, AL, clozapine ODT G QL, 5DS, AL G Clozaril NF caffeine/codeine MME codeine tabs G QL, 5DS, AL, MME Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 22
DRUG REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER LIMITS TIER LIMITS coditussin AC diazepam tabs LCG G QL, AL, 5DS, MME liquid Diclofenac cap 35mg NF Comtan NF Concerta NF QL diclofenac G Contrave ER NPD PA, R potassium Conzip NF QL, AL, MME diclofenac sodium G Copaxone NF, SP QL diclofenac sodium G gel 1% Cotempla XR- NF QL diethylpropion ODT G R, PA HCL Cymbalta NF diflunisal G Dantrium NF QL, 5DS, AL, dihydrocodeine/ dantrolene G G APAP/caff MME Daypro NF dihydrocodeine/ QL, 5DS, AL, G Daytrana + NPD PA, QL aspirin/caffeine MME Dayvigo NF QL dihydroergo- G PA Demerol NF QL, 5DS, MME tamine inj Depakene NF dihydroergo- tamine mesylate G PA Depakote NF nasal spray Depakote ER NF Dilantin chewable tablets PB Depakote NF Sprinkle Caps Dilaudid NF QL, MME, 5DS desipramine G dimethyl fumarate G, SP Desoxyn NF QL DR cap Desvenlafaxine disulfiram G ER 24HR PB divalproex sodium G desvenlafaxine divalproex sodium G G PA, QL succinate ER ER Dexedrine caps NF QL divalproex G dexmethyl- sprinkle cap G QL phenidate ER Dolophine NF QL, MME dexmethyl- donepezil G QL G AL phenidate hcl hydrochloride dextroam- Doral NF AL G QL phetamine doxepin capsule G dextroam- doxepin tablet G PA G QL phetamine ER Drizalma D.H.E.45 NF Sprinkle NF Diacomit NPD, SP PA duloxetine G Diastat NPD Duragesic patch NF QL, MME diazepam solution G Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 23
DRUG DRUG REQUIREMENTS/ REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER TIER LIMITS LIMITS TIER LIMITS Dyanavel XR NF QL Fetzima + NPD PA Edluar SL tab NPD PA, QL Fintepla sol NF Effexor XR NF Fioricet NF QL, 5DS Eldepryl NF Fioricet QL, AL, 5DS, with codeine NF Elepsia XR NF MME eletriptan G QL, AL Fiorinal QL, AL, 5DS, with codeine NF MME Embeda NF QL, MME fluoxetine G QL (Weekly Only) Emgality PB PA, QL fluoxetine endocet G QL, 5DS, MME LCG 10mg, 20mg, 40mg entacapone G fluoxetine soln G AL Epidiolex Soln NPD PA fluphenazine G ergotamine G flurazepam G QL, AL tartrate/caffeine flurbiprofen G escitalopram LCG fluvoxamine G esgic capsule G QL, 5DS fluvoxamine ER G Esgic tablet NF QL, 5DS Focalin NF QL estazolam G QL, AL Focalin XR NF QL eszopiclone G PA, QL (3mg only) ForFivo XL NF ethosuximide G Frova NF QL, AL etodolac G frovatriptan Evekeo [ODT] NF QL NPD QL, AL succinate Evzio NF QL Fycompa NPD Exalgo ER NF QL, MME gabapentin G Exelon NF AL gabapentin soln G AL Exservan Mis NPD Gabitril NF Extavia NF, SP QL galantamine G AL Fanapt + NPD PA galantamine ER G AL Fazaclo NPD Geodon NF felbamate G Gilenya NPD, SP Felbatol NF glatiramer acetate G, SP QL Feldene NF glatopa G, SP QL fenoprofen Gocovri NF G calcium Gralise Mis NF fentanyl citrate guaifenesin- G PA, QL, MME QL, AL, 5DS, OTFC codeine soln G Fentanyl citrate 10mg/5ml MME tablet NF QL, MME guanfacine ER G QL Fentora NF QL, MME Halcion + NF QL, AL Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 24
DRUG DRUG REQUIREMENTS/ REQUIREMENTS/ DRUG REQUIREMENTS/ DRUG NAME DRUG NAME TIER TIER LIMITS LIMITS TIER LIMITS haloperidol G Kynmobi Mis NPD, SP PA, QL Hetlioz Cap NPD, SP PA, QL Kynmobi Kit Titration NPD, SP PA Hetlioz LQ Susp NPD, SP PA Horizant NPD PA Lamictal NF hydrocodone/ QL, 5DS, AL, Lamictal ODT NF G Lamictal XR acetaminophen MME NF hydrocodone- QL, 5DS, AL, lamotrigine G G homatropine MME lamotrigine ER G hydrocodone ER G PA, QL, MME lamotrigine ODT G hydromorphone ER G PA, QL, MME Latuda + NPD PA hydromorphone IR G QL, 5DS, MME Lazanda NF QL, MME Hysingla ER NF QL, MME levetiracetam G QL, 5DS, MME, levetiracetam ER G Ibudone NF AL levorphanol G QL, 5DS, MME ibuprofen/ QL, 5DS, MME, Lexapro NF G hydrocodone AL Librax NF Imcivree NPD, SP PA lithium carbonate G 10mg/ml Inj lithium carbonate imipramine G G ER Imitrex NF AL, QL Lodine NF Inbrija NPD, SP PA Lodosyn NF Indocin susp NPD AL Lomaira NPD PA, R Ingrezza NPD, SP PA lorazepam LCG AL Intermezzo NF QL lorazepam G AL Intuniv NF QL concentrate Invega ER tablet NF Lortab NF QL, 5DS, AL isometheptene/ loxapine G dichloral- G Lunesta NF QL phenazone/apap Lyrica NF Jakafi NPD, SP PA, LDD Lyrica CR NF Jornay PM NF QL Lyrica soln NF AL Capsule maprotiline G Kadian ER NF QL, MME Maxalt, Maxalt- Kapvay NF QL MLT NF AL, QL Keppra NF Mayzent tablet, Keppra XR NF starter pak NPD, SP ketorolac G m-clear WC soln G AL, QL Khedezla NF meclofenamate G Klonopin NF memantine G AL Bold type = Brand Name Drug Lower case italic = Generic drug PA = Prior Authorization QL = Quantity Limits Apply SP = Specialty Drug AL = Age Limit LCG = Low Cost Generic LDD = Limited Distribution Drug 5DS = Day Supply Limit R = Requires Rider + = PA for Selected NPD NF = Non Formulary G = Generic Q/T = Quantity Over Time PB = Preferred Brand NPD = Non Preferred Drug ACA = $0 Preventative Drug MME = Morphine Milligram Equivalent 25
You can also read